US News & World Report – Genetic Tests Predict Response to Warfarin Variations of a gene that determines a person’s sensitivity to warfarin are important in determining the initial doses of th
Tucson Citizen – Blood Thinner Safety Effort Touted A Tucson-based research institute says it is improving the safety of a widely used blood thinning drug.
Alastair J.J. Wood Joins the Critical Path Institute Board of Directors Dr. Alastair J.J. Wood, drug development authority, frequent advisor to the Food and Drug Administration (FDA) and former Assistan
Peter Corr Joins the Critical Path Institute Board of Directors The Critical Path Institute today announced that Peter B. Corr, Ph.D., has joined its Board of Directors. Dr. Corr has more than 3
C-Path and Ventana Medical Systems to Collaborate The Critical Path Institute (C-Path) and Ventana Medical Systems, Inc. (Ventana) (NASDAQ: VMSI) today released additional informat
C-Path Awarded Grant to Continue Drug Safety Work The Critical Path Institute (C-Path) announced the receipt of a $4 million grant from the Agency for Healthcare Research and Quali
Arizona State Governor Janet Napolitano Awards C-Path with the 2007 Arizona Innovation Award Thanks to C-Path’s role as an independent, neutral third party, it has been successful in bringing together scientists from
Science Foundation Arizona Announces $10 Million in Grants to Fund Research Collaboration With Industry Science Foundation Arizona (SFAz), through its Strategic Research Group (SRG) program, today announced that it is granting nearly
C-Path Makes Progress to Safely Speed Medical Discoveries to Market William Mattes of C-Path spoke at the Arizona Pavillion May 8th 2007 about the Predictive Safety Testing Consortium.
